Se connecter S'abonner en ligne
  • Infos sociétés
  • Infos OPCVM
  • Alertes e-mail
  • Notre offre
 Langues  Par thème  Par secteur d'activité  Par pays
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
Medacta Group SA [CH0468525222]   
[13/03/2024]

Medacta Group SA : Medacta Group SA: Medacta Group SA reports robust revenue growth of 19.5% at constant currency and adjusted EBITDA1 margin 26.3%, or 27.9% at constant currency in FY 2023

Medacta Group SA / Key words: Annual Results/Annual Results Medacta Group SA: Medacta Group SA reports robust revenue growth of 19.5% at constant currency and adjusted EBITDA1 margin 26.3%, or 27.9% at constant currency in FY 2023 13March2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the con... Lire le communiqué
 
Medacta Group SA [CH0468525222]   
[12/02/2024]

Medacta Group SA : Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at AAOS 2024

Medacta Group SA / Key words: Miscellaneous Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at AAOS 2024 12.02.2024 / 19:00 CET/CEST MEDIA RELEASE Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at AAOS 2024 CASTEL SAN PIETRO, 12 February 2024 Medac... Lire le communiqué
 
Medacta Group SA [CH0468525222]   
[02/02/2024]

Medacta Group SA : Medacta Group SA: Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln € in FY 2023

Medacta Group SA / Key words: Sales Result Medacta Group SA: Medacta Group SA revenues up 19.5% at constant currency1 exceeding the milestone of 500Mln € in FY 2023 02Feb2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Pr... Lire le communiqué
 
Medacta Group SA [CH0468525222]   
[08/01/2024]

Medacta Group SA : Medacta’s QUADRA-H hip stem achieves 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP)

Medacta Group SA / Key words: Miscellaneous Medacta’s QUADRAH hip stem achieves 13A exemplary quality rating from the British Orthopaedic Data Evaluation Panel ODEP 08.01.2024 / 19:00 CET/CEST MEDIA RELEASE Medacta’s QUADRAH hip stem achieves 13A exemplary qu... Lire le communiqué
 
Medacta Group SA [CH0468525222]   
[14/12/2023]

Medacta Group SA : A new clinical study highlights efficiency in spine surgery of NextAR Spine, augmented reality surgical application

Medacta Group SA / Key words: Study results/Study results A new clinical study highlights efficiency in spine surgery of NextAR Spine, augmented reality surgical application 14.12.2023 / 19:00 CET/CEST MEDIA RELEASE A new clinical study highlights efficiency in spine surgery of NextAR Spine, augmented re... Lire le communiqué
 
Medacta Group SA [CH0468525222]   
[29/11/2023]

Medacta Group SA : Medacta further expands in Rancate, Switzerland, doubling its production capability to support the future growth

Medacta Group SA / Key words: Expansion/Expansion Medacta further expands in Rancate, Switzerland, doubling its production capability to support the future growth 29.11.2023 / 19:00 CET/CEST Media Release Medacta further expands in Rancate, Switzerland, doubling its production capability to support th... Lire le communiqué
 
Medacta Group SA [CH0468525222]   
[30/10/2023]

Medacta Group SA : Medacta Announces the Launch of GMK SpheriKA, the World's First Knee Implant Optimized for Kinematic Alignment (KA)

Medacta Group SA / Key words: Product Launch/Product Launch Medacta Announces the Launch of GMK SpheriKA, the Worlds First Knee Implant Optimized for Kinematic Alignment KA 30.10.2023 / 07:00 CET/CEST MEDIA RELEASE Medacta Announces the Launch of GMK SpheriKA, the Worlds First Knee Implant Optimiz... Lire le communiqué
 
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...


Vidéos
Gestionnaires,
Emetteurs,
Ma sélection
Les communiqués les plus lus de Medacta...